Sr. Scientist II
Abbvie
South San Francisco, California
Elissa Grzincic is a biologics drug product development / formulations senior scientist at AbbVie at the South San Francisco site, specializing in drug product development of complex biologics, particularly early-stage. Elissa is a subject matter expert in clinical in-use topics (including closed system transfer devices) and protein characterization (including characterization method development, particularly for low concentration samples). Previously, she spent 4 years in the drug product development group at Nektar Therapeutics, which focused on late-stage development of a PEGylated cytokine pro-drug. Elissa earned a PhD in Chemistry at the University of Illinois at Urbana-Champaign and completed a post-doc at Lawrence Berkeley National Lab.
Closed System Transfer Devices for Dose Preparation of Low-Dose Biologics
Wednesday, October 25, 2023
3:45 PM – 4:00 PM ET